256 related articles for article (PubMed ID: 25619588)
1. Soluble CD36 in plasma and urine: a plausible prognostic marker for diabetic nephropathy.
Shiju TM; Mohan V; Balasubramanyam M; Viswanathan P
J Diabetes Complications; 2015 Apr; 29(3):400-6. PubMed ID: 25619588
[TBL] [Abstract][Full Text] [Related]
2. Identification of the oxidized low-density lipoprotein scavenger receptor CD36 in plasma: a novel marker of insulin resistance.
Handberg A; Levin K; Højlund K; Beck-Nielsen H
Circulation; 2006 Sep; 114(11):1169-76. PubMed ID: 16952981
[TBL] [Abstract][Full Text] [Related]
3. Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy.
Wang Y; Li YM; Zhang S; Zhao JY; Liu CY
J Int Med Res; 2016 Apr; 44(2):278-86. PubMed ID: 26857862
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients.
Liani R; Halvorsen B; Sestili S; Handberg A; Santilli F; Vazzana N; Formoso G; Aukrust P; Davì G
Free Radic Biol Med; 2012 Apr; 52(8):1318-24. PubMed ID: 22343420
[TBL] [Abstract][Full Text] [Related]
5. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
Wang QY; Chen FQ
Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668
[TBL] [Abstract][Full Text] [Related]
7. Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
Elsheikh M; Elhefnawy KA; Emad G; Ismail M; Borai M
J Bras Nefrol; 2019; 41(4):509-517. PubMed ID: 30897192
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress markers in type 2 diabetes patients with diabetic nephropathy.
Chou ST; Tseng ST
Clin Exp Nephrol; 2017 Apr; 21(2):283-292. PubMed ID: 27233502
[TBL] [Abstract][Full Text] [Related]
9. Changes of transforming growth factor beta 1 in patients with type 2 diabetes and diabetic nephropathy: A PRISMA-compliant systematic review and meta-analysis.
Qiao YC; Chen YL; Pan YH; Ling W; Tian F; Zhang XX; Zhao HL
Medicine (Baltimore); 2017 Apr; 96(15):e6583. PubMed ID: 28403088
[TBL] [Abstract][Full Text] [Related]
10. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus.
Vijay S; Hamide A; Senthilkumar GP; Mehalingam V
Diabetes Metab Syndr; 2018 Sep; 12(5):649-652. PubMed ID: 29673928
[TBL] [Abstract][Full Text] [Related]
11. Association of circulatory asymmetric dimethylarginine (ADMA) with diabetic nephropathy in Asian Indians and its causative role in renal cell injury.
Jayachandran I; Sundararajan S; Paramasivam P; Venkatesan B; Subramanian SC; Balasubramanyam M; Mohan V; Manickam N
Clin Biochem; 2017 Oct; 50(15):835-842. PubMed ID: 28495185
[TBL] [Abstract][Full Text] [Related]
12. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
Senatorski G; Paczek L; Kropiewnicka E; Bartłomiejczyk I
Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778
[TBL] [Abstract][Full Text] [Related]
13. Is plasma-soluble CD36 associated with density of atheromatous plaque and ankle-brachial index in early-onset coronary artery disease patients?
Rać M; Krzystolik A; Rać M; Safranow K; Dziedziejko V; Goschorska M; Poncyljusz W; Chlubek D
Kardiol Pol; 2016; 74(6):570-5. PubMed ID: 26620683
[TBL] [Abstract][Full Text] [Related]
14. Osteoinductive factor is a novel biomarker for the diagnosis of early diabetic nephropathy.
Wang S; Wang Y; Zheng R; Zhao Z; Ma Y
Int J Clin Exp Pathol; 2015; 8(3):3110-5. PubMed ID: 26045825
[TBL] [Abstract][Full Text] [Related]
15. Microalbuminuria, Other Markers of Nephropathy and Biochemical Derangementsin Type 2 Diabetes Mellitus: Relationships and Determinants.
Idowu AA; Ajose AO; Adedeji AT; Adegoke AO; Jimoh KA
Ghana Med J; 2017 Jun; 51(2):56-63. PubMed ID: 28955101
[TBL] [Abstract][Full Text] [Related]
16. [Change and significance of urinary smad3 in type 2 diabetic nephropathy].
Guo KF; Kou JX; Lu JX; Zhang L; Yu HY; Chen HB
Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(14):1067-71. PubMed ID: 23902838
[TBL] [Abstract][Full Text] [Related]
17. Urinary RBP and NGAL Levels are Associated with Nephropathy in Patients with Type 2 Diabetes.
Wu J; Shao X; Lu K; Zhou J; Ren M; Xie X; Liu J; Xu Y; Ding Y; Shen X; Zhu C
Cell Physiol Biochem; 2017; 42(2):594-602. PubMed ID: 28954270
[TBL] [Abstract][Full Text] [Related]
18. Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy.
Piwowar A; Knapik-Kordecka M; Szczecińska J; Warwas M
Diabetes Metab Res Rev; 2008 Oct; 24(7):549-53. PubMed ID: 18613218
[TBL] [Abstract][Full Text] [Related]
19. [Urine TGF-beta1 concentration in patients with type II diabetes mellitus--prognostic values].
Paczek L; Kropiewnicka HE; Senatorski G; Bartłomiejczyk I
Pol Arch Med Wewn; 2002 Aug; 108(2):745-52. PubMed ID: 12476894
[TBL] [Abstract][Full Text] [Related]
20. The Profile of Plasma Free Amino Acids in Type 2 Diabetes Mellitus with Insulin Resistance: Association with Microalbuminuria and Macroalbuminuria.
Saleem T; Dahpy M; Ezzat G; Abdelrahman G; Abdel-Aziz E; Farghaly R
Appl Biochem Biotechnol; 2019 Jul; 188(3):854-867. PubMed ID: 30706418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
